SCHEMBL7760415

SCHEMBL7760415

Fc1ccccc1Oc1ccn[c]n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAP4K4 O95819 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ESR1 P03372 1/20 0.38
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
HTR1A P08908 3/20 0.35
SLC6A2 P23975 3/20 0.35
SLC6A3 Q01959 2/20 0.35
PARP10 Q53GL7 1/20 0.35
CXCL8 P10145 1/20 0.35
HSPB1 P04792 1/20 0.35
MAPK1 P28482 1/20 0.35
RHEB Q15382 1/20 0.34
MRGPRX1 Q96LB2 3/20 0.34
SLC6A4 P31645 1/20 0.34
BRAF P15056 1/20 0.33
GCK P35557 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11105483 0.79 ADRA2A (0.37) MEN1KMT2AKDM4ELMNAHTR1A
SCHEMBL17746786 0.76 POLB (0.44) MAP4K4HTR1AGCK
SCHEMBL558025 0.74 LTA4H (0.42) MEN1KMT2AALDH1A1KDM4EHTT
SCHEMBL9684728 0.74 MEN1 (0.46) MEN1KMT2AMAP4K4ALDH1A1ESR1
SCHEMBL2044641 0.71 MEN1 (0.59) MEN1KMT2AMAP4K4ALDH1A1ESR1
SCHEMBL18984674 0.71 MEN1 (0.59) MEN1KMT2AMAP4K4ALDH1A1ESR1
SCHEMBL2389927 0.70 HTR1A (0.55) MEN1KMT2AALDH1A1ESR1KDM4E
SCHEMBL30773497 0.70 HTR1A (0.55) MEN1KMT2AALDH1A1ESR1KDM4E
SCHEMBL16541082 0.69 MEN1 (0.53) MEN1KMT2AMAP4K4ALDH1A1ESR1
SCHEMBL27606810 0.68 MEN1 (0.47) MEN1KMT2AMAP4K4ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736907-B1 INDAZOLES PFIZER LTD (GB) 2015-10-07 EP disclosed
US-8895544-B2 Indazoles PFIZER LIMITED (GB) 2014-11-25 US disclosed
EP-2736907-A1 INDAZOLES Pfizer Limited (GB) 2014-06-04 EP disclosed
US-20140024634-A1 INDAZOLES PFIZER LIMITED (GB) 2014-01-23 US disclosed
US-8575336-B2 Indazoles PFIZER LIMITED (GB) 2013-11-05 US disclosed
WO-2013014567-A1 INDAZOLES PFIZER LIMITED (GB) 2013-01-31 WO disclosed
US-20130029968-A1 INDAZOLES PFIZER LIMITED (GB) 2013-01-31 US disclosed
US-6211190-B1 Pyrimidine derivatives, process and intermediate products for their preparation and pesticides or fungicides containing these derivatives BASF AKTIENGESELLSCHAFT (DE) 2001-04-03 US disclosed
EP-0873305-B1 AZINOOXIMETHERS, PROCESSES AND INTERMEDIATE PRODUCTS FOR MANUFACTURING SAME, AND THE USES THEREOF IN COMBATING HARMFUL FUNGI AND PESTS BASF AG (DE) 2001-03-28 EP disclosed
US-6200997-B1 CYCLIZATION TO GIVE OXAZOLIDINEDIONES AND TRIAZOLIDINEDIONES BASF AKTIENGESELLSCHAFT (DE) 2001-03-13 US disclosed
EP-0873307-B1 CYANIMINO OXIME ETHERS, PROCESS AND INTERMEDIATES FOR THE PREPARATION AND USE THEREOF FOR THE CONTROL OF NOXIOUS FUNGI AND ANIMAL PESTS BASF AG (DE) 2000-05-31 EP disclosed
US-6063813-A FUNGICIDES AND INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-05-16 US disclosed
US-6043282-A FUNGICIDES, PESTICIDES, INSECTICIDES, NEMATOCIDES, MITICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-03-28 US disclosed
CN-1161687-A Phenylacetic acid alkyl esters BASF AG (DE) 1997-10-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029968-A1 INDAZOLES CYP11B2, CYP11B1, IL33 MEN1 4249/4885KMT2A 4073/4885MAP4K4 3559/4885
US-20140024634-A1 INDAZOLES JAK1, JAK3, JAK2 MEN1 4364/4885KMT2A 2168/4885MAP4K4 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.